Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial.
about
Neural correlates of cognitive improvements following cognitive remediation in schizophrenia: a systematic review of randomized trialsUnmet needs in the management of schizophreniaTowards medication-enhancement of cognitive interventions in schizophreniaNeuroplasticity-based auditory training via laptop computer improves cognition in young individuals with recent onset schizophreniaSocial-cognitive remediation in schizophrenia: generalization of effects of the Training of Affect Recognition (TAR).Are we studying and treating schizophrenia correctly?Social cognition in schizophrenia, Part 2: 12-month stability and prediction of functional outcome in first-episode patients.Prefrontal gray matter morphology mediates the association between serum anticholinergicity and cognitive functioning in early course schizophrenia.Clinical trials of potential cognitive-enhancing drugs in schizophrenia: what have we learned so far?Neuropsychological and functional outcomes in recent-onset major depression, bipolar disorder and schizophrenia-spectrum disorders: a longitudinal cohort study.Neurocognitive functioning of individuals with schizophrenia: using and not using drugs.Multifamily group psychoeducation and cognitive remediation for first-episode psychosis: a randomized controlled trial.Psychosocial treatments for negative symptoms in schizophrenia: current practices and future directions.Neural responses during social reflection in relatives of schizophrenia patients: relationship to subclinical delusions.One-year durability of the effects of cognitive enhancement therapy on functional outcome in early schizophreniaDoes change in cognitive function predict change in costs of care for people with a schizophrenia diagnosis following cognitive remediation therapy?BRIEF REPORT: THE IMPACT OF ALCOHOL AND CANNABIS MISUSE ON COGNITION AMONG INDIVIDUALS WITH SCHIZOPHRENIA.A randomized controlled trial of cognitive remediation and d-cycloserine for individuals with bipolar disorder.Cognitive Enhancement Therapy in substance misusing schizophrenia: results of an 18-month feasibility trial.The FOCUS trial: cognitive remediation plus standard treatment versus standard treatment for patients at ultra-high risk for psychosis: study protocol for a randomised controlled trialEarly intervention in psychotic disorders: Challenges and relevance in the Indian context.A systematic review on improving cognition in schizophrenia: which is the more commonly used type of training, practice or strategy learning?One-year randomized controlled trial and follow-up of integrated neurocognitive therapy for schizophrenia outpatients.A broad cortical reserve accelerates response to cognitive enhancement therapy in early course schizophrenia.Relationship of neurocognitive deficits to diagnosis and symptoms across affective and non-affective psychoses.Open-ended and Open-door Treatment Groups for Young People with Mental IllnessTreatment of early onset schizophrenia: recent trends, challenges and future considerations.Are neurocognitive, clinical and social dysfunctions in schizotaxia reversible pharmacologically?: Results from the Changsha studyAddition of home-based cognitive retraining to treatment as usual in first episode schizophrenia patients: a randomized controlled studyDo Apparent Overlaps between Schizophrenia and Autistic Spectrum Disorders Reflect Superficial Similarities or Etiological Commonalities?Neurocognitive and clinical dysfunction in adult Chinese, nonpsychotic relatives of patients with schizophrenia: Findings from the Changsha study and evidence for schizotaxia.Neurocognitive and social cognitive approaches for improving functional outcome in early psychosis: theoretical considerations and current state of evidence.Social cognitive training for schizophrenia: a meta-analytic investigation of controlled research.Development of the Positive Emotions Program for Schizophrenia: An Intervention to Improve Pleasure and Motivation in Schizophrenia.Compensatory cognitive training for psychosis: effects in a randomized controlled trial.Structural neurobiological correlates of Mayer-Salovery-Caruso Emotional Intelligence Test performance in early course schizophrenia.Cognitive remediation improves memory and psychosocial functioning in first-episode psychiatric out-patients.Cognitive remediation: a new generation of psychosocial interventions for people with schizophreniaMechanisms of functional improvement in a 2-year trial of cognitive enhancement therapy for early schizophrenia.Negative symptom improvement during cognitive rehabilitation: results from a 2-year trial of Cognitive Enhancement Therapy.
P2860
Q26753204-77664A7F-0B2E-482D-98BA-437E4CC57030Q26822917-EB18F896-E586-40C6-8113-D014DD87DFA6Q26860777-785AADE9-C386-4B30-9212-29E07FE8D0B5Q27320479-FA585846-F221-4E4D-A016-6211C481D29DQ30464307-F75011DB-FC94-41AE-BA9D-D4F30AB380AEQ30465313-52ABA607-A3E2-4608-8A4B-B0F7F7205CB6Q30523052-C20464DC-979A-4DA3-B1EB-DAC729FF1E50Q30529640-D545FD34-A177-4214-B6E9-18B8FE54A637Q30536299-D377ECFA-5E98-45FE-A1F0-F7C9E262AA53Q30654007-F2C25F1F-3377-4D28-B67C-1B072F7B1549Q33762494-B564C598-FD6B-4378-B8E8-0D54CDF930F8Q33791337-4D7D8F5A-874C-43DD-8A32-5CF5498F68B7Q33882729-490AA27F-591F-453C-81E2-2AD6FF041CC3Q33944967-C26D943E-3408-47EC-92FA-6E24FCA822E4Q33976280-A0439C5F-B364-47B0-A15F-A4BD532064CFQ34323024-7EAD346C-AA43-4409-ACA4-E3C0FA527E01Q34530176-C3F830A6-C68C-48D5-BDD7-85C4D1B1FAFEQ34729257-28838B5D-B50B-4E14-8F25-B3C1E01FE269Q35019827-ED1F8A43-7407-48FE-BA94-5DA339B9FED6Q35052697-6E6136ED-D621-4C6A-AF9D-EE99CF714B5DQ35135578-13B66C36-C8A8-47AC-B498-CC99E777C611Q35178429-7A752774-5877-4D76-849B-C82DBDF2E49CQ35369948-BD9A959F-A7F4-4870-8FD9-F8E2D8B0F5ABQ35532688-EC9606C5-A70A-4754-AAB0-DEEAE03BF942Q35577541-8A41B760-0750-4F5F-929C-98166FE336E4Q35834384-76E5ED5D-D5D2-4F56-B8BF-EF850AC1C8A9Q35864793-FE9CD3E7-2016-4186-BB0E-F622EAB32A8AQ35873996-531C60AF-0796-471E-90F5-FAAE857CA2CFQ35919571-82B764BD-A319-443B-A4F5-DFE92E72C064Q35929126-42D7F55C-97C5-4871-ADBC-59A7248BD02CQ36072702-6F4DDE56-A645-432F-AC58-A39D58AEA610Q36169003-59018222-9DC0-47B6-B77F-5ADAB16E5B10Q36245000-978EEAF5-C3B3-4903-9601-FC79F2EC5899Q36587030-8F71967F-A4D7-42BE-8A73-BAAE4B62EB20Q36672355-77A0B830-B74B-4026-B373-2C5AB4B8A856Q36792091-993B6858-A758-43C6-8A80-EA227D046E5AQ36812828-475DE64A-D917-43E3-A8FD-066A0C994C51Q36930812-F5CA0BF4-47EA-4D0F-B86B-87045593ABFBQ37001491-3DC3376E-74D1-445B-ACF0-256782614128Q37067541-53F14F39-A6B5-4196-ADEE-430645B9E0A3
P2860
Cognitive enhancement therapy for early-course schizophrenia: effects of a two-year randomized controlled trial.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Cognitive enhancement therapy ...... r randomized controlled trial.
@en
type
label
Cognitive enhancement therapy ...... r randomized controlled trial.
@en
prefLabel
Cognitive enhancement therapy ...... r randomized controlled trial.
@en
P2093
P2860
P1433
P1476
Cognitive enhancement therapy ...... r randomized controlled trial.
@en
P2093
Ann Louise DiBarry
Deborah P Greenwald
Debra M Montrose
Shaun M Eack
Susan J Cooley
Susan S Hogarty
P2860
P304
P356
10.1176/PS.2009.60.11.1468
P577
2009-11-01T00:00:00Z